Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 455031Generated: October 25, 2026

3-((1H-imidazol-1-yl)methyl)-6-methyl-2-p-tolylimidazo[1,2-a]pyridine → 3-((1H-tetrazol-1-yl)methyl)-2-(4-chlorophenyl)imidazo[1,2-a]pyridine

https://huagongshe.com/reaction/455031

Reaction equation

Participants

RoleNameHCIDCharge
Reactant3-((1H-imidazol-1-yl)methyl)-6-methyl-2-p-tolylimidazo[1,2-a]pyridineHCID 58337071—
Reactant3-(Chloromethyl)-2-(4-chlorophenyl)imidazo[1,2-a]pyridine hydrochlorideHCID 67028719—
ReactantHCID 178418441HCID 178418441—
Product3-((1H-tetrazol-1-yl)methyl)-2-(4-chlorophenyl)imidazo[1,2-a]pyridineHCID 67028694—

Reaction Steps

The title compound was prepared according to Method A and the experimentals described for compound 1 from 3-(chloromethyl)-2-(4-chlorophenyl)imidazo[1,2-a]pyridine hydrochloride and 1H-tetrazole. M/e+ 311 for C15H12ClN6 (M+H)+; 1H-NMR (400 MHz, CDCl3) δ 8.45 (s, 1H), 8.12 (d, J=6.9 Hz, 1H), 7.73 (d, J=9.1 Hz, 1H), 7.64 (d, J=8.4 Hz, 2H), 7.50 (d, J=8.4 Hz, 2H), 7.37 (td, J=6.9, 1.1 Hz, 1H), 6.97 (m, 1H), 6.03 (s, 2H) ppm.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08497278B2
Source datasetuspto-grants-2013_07
ORD IDord-b9705faedb7b4edabac5c7e424b74e1c
Source noteuspto-grants-2013_07